In Alzheimer’s disease, BChE activity increases during advanced stages, while acetylcholinesterase (AChE) levels decline markedly, suggesting a compensatory mechanism in cholinergic signaling and cognitive function (Xing et al., 2021). The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.